Michał Juszyński
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michał Juszyński has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Grzegorz Madycki
4 shared publications- Anna Ratajska
Department of Pathological Anatomy, Medical University of Warsaw, Poland
3 shared publications - Anna Jabłońska
Department of Ophthalmology, Medical University of Warsaw, 02-091 Warsaw, Poland
2 shared publications - Bogdan Ciszek
Department of Descriptive and Clinical Anatomy, Center for Biostructure Research, Medical University of Warsaw, Warsaw, Poland
2 shared publications Emilia Stachurska
Department of Pathological Anatomy, Medical University of Warsaw, Warszawa, Poland
2 shared publicationsAgnieszka Loboda
Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland
1 shared publication
Latest Publications
- 1 December 2019
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 58 (6) , e812
Prevalence and Predictive Value of the Thrombin-Antithrombin Complex Levels in Patients with Abdominal Aortic Aneurysm and Peripheral Arterial Disease Undergoing Endovascular Interventions
- 1 December 2019
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 58 (6) , e812
Prevalence and Predictive Value of the Thrombin-Antithrombin Complex Levels in Patients with Abdominal Aortic Aneurysm and Peripheral Arterial Disease Undergoing Endovascular Interventions
- 1 December 2019
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 58 (6) , e316
High On-treatment Platelet Reactivity and Low Platelet Response to Aspirin in Patients with Peripheral Arterial Disease Undergoing Percutaneous Transluminal Angioplasty of the Arteries of the Lower Limbs
- 1 December 2019
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 58 (6) , e316
High On-treatment Platelet Reactivity and Low Platelet Response to Aspirin in Patients with Peripheral Arterial Disease Undergoing Percutaneous Transluminal Angioplasty of the Arteries of the Lower Limbs
- 1 December 2019
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 58 (6) , e442
High On-treatment Platelet Reactivity and Low Platelet Response to Aspirin in Patients with Peripheral Arterial Disease Treated with Percutaneous Transuminal Angioplasty of the Arteries of the Lower Limbs – Single-centered Study
- 1 December 2019
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 58 (6) , e442
High On-treatment Platelet Reactivity and Low Platelet Response to Aspirin in Patients with Peripheral Arterial Disease Treated with Percutaneous Transuminal Angioplasty of the Arteries of the Lower Limbs – Single-centered Study
- 5 November 2019
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 130 (1) , 79-81
Sulodexide improves capillary blood flow and the quality of life in patients with Raynaud syndrome – a pilot study
- 5 November 2019
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 130 (1) , 79-81
Sulodexide improves capillary blood flow and the quality of life in patients with Raynaud syndrome – a pilot study
- Open Access
- 16 March 2011
- Published by Frontiers Media SA in Acta Biochimica Polonica
- Vol. 58 (1) , 19-29
Expression of cellular retinoic acid-binding protein I and II (CRABP I and II) in embryonic mouse hearts treated with retinoic acid.
Cellular retinoic acid binding proteins are considered to be involved in retinoic acid (RA) signaling pathways. Our aim was to compare the expression and localization of cellular retinoic acid binding proteins I and II (CRABP I and II) in embryonic mouse hearts during normal development and after a single teratogenic dose of RA. Techniques such as real-time PCR, RT-PCR, Western blots and immunostaining were employed to examine hearts from embryos at 9-17 dpc. RA treatment at 8.5dpc affects production of CRABP I and II in the heart in the 48-h period. Changes in expression of mRNA for retinaldehyde dehydrogenase II (Raldh2), Crabp1 and Crabp2 genes also occur within the same time window (i.e. 10-11dpc) after RA treatment. In the embryonic control heart these proteins are localized in groups of cells within the outflow tract (OT), and the atrioventricular endocardial cushions. A gradient of labeling is observed with CRABP II but not for CRABP I along the myocardium of the looped heart at 11 dpc; this gradient is abolished in hearts treated with RA, whereas an increase of RALDH2 staining has been observed at 10 dpc in RA-treated hearts. Some populations of endocardial endothelial cells were intensively stained with anti-CRABP II whereas CRABP I was negative in these structures. These results suggest that CRABP I and II are independently regulated during heart development, playing different roles in RA signaling, essential for early remodeling of the heart tube and alignment of the great arteries to their respective ventricles.
- 16 March 2011
- Published by Frontiers Media SA in Acta Biochimica Polonica
- Vol. 58 (1) , 19-29
Open AccessExpression of cellular retinoic acid-binding protein I and II (CRABP I and II) in embryonic mouse hearts treated with retinoic acid.
Cellular retinoic acid binding proteins are considered to be involved in retinoic acid (RA) signaling pathways. Our aim was to compare the expression and localization of cellular retinoic acid binding proteins I and II (CRABP I and II) in embryonic mouse hearts during normal development and after a single teratogenic dose of RA. Techniques such as real-time PCR, RT-PCR, Western blots and immunostaining were employed to examine hearts from embryos at 9-17 dpc. RA treatment at 8.5dpc affects production of CRABP I and II in the heart in the 48-h period. Changes in expression of mRNA for retinaldehyde dehydrogenase II (Raldh2), Crabp1 and Crabp2 genes also occur within the same time window (i.e. 10-11dpc) after RA treatment. In the embryonic control heart these proteins are localized in groups of cells within the outflow tract (OT), and the atrioventricular endocardial cushions. A gradient of labeling is observed with CRABP II but not for CRABP I along the myocardium of the looped heart at 11 dpc; this gradient is abolished in hearts treated with RA, whereas an increase of RALDH2 staining has been observed at 10 dpc in RA-treated hearts. Some populations of endocardial endothelial cells were intensively stained with anti-CRABP II whereas CRABP I was negative in these structures. These results suggest that CRABP I and II are independently regulated during heart development, playing different roles in RA signaling, essential for early remodeling of the heart tube and alignment of the great arteries to their respective ventricles.
- 20 March 2009
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 85 (7) , 599-610
Angioarchitecture of the venous and capillary system in heart defects induced by retinoic acid in mice
BACKGROUND: Corrosion casting and immunohistochemical staining with anti‐alpha smooth muscle actin and anti‐CD34 was utilized to demonstrate the capillary plexus and venous system in control and malformed mouse hearts. METHODS: Outflow tract malformations (e.g., double outlet right ventricle, transposition of the great arteries, and common truncus arteriosus) were induced in progeny of pregnant mice by retinoic acid administration at day 8.5 of pregnancy. RESULTS: Although control hearts exhibited areas in which capillaries tended to be oriented in parallel arrays, the orientation of capillaries in the respective areas of malformed hearts was chaotic and disorganized. The major branch of a conal vein in control hearts runs usually from the left side of the conus to its right side at the root of the pulmonary trunk and opens to the right atrium below the right auricle; thus, it has a curved course. On the other hand, a conal vein in malformed hearts courses from the left side or from the anterior side of the conus and tends to traverse straight upwards along the dextroposed aorta or along the aortopulmonary groove with its proximal part located outside of the heart. Other cardiac veins in outflow tract malformations are positioned in the same locations as in control hearts. CONCLUSIONS: We postulate that the changed location of the conal vein and disorganized capillary plexus result from malformed morphogenesis of the outflow tract and/or a disturbed regulation of angiogenic growth factor release from the adjacent environment. Birth Defects Research (Part A), 2009.
- 20 March 2009
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 85 (7) , 599-610
Angioarchitecture of the venous and capillary system in heart defects induced by retinoic acid in mice
BACKGROUND: Corrosion casting and immunohistochemical staining with anti‐alpha smooth muscle actin and anti‐CD34 was utilized to demonstrate the capillary plexus and venous system in control and malformed mouse hearts. METHODS: Outflow tract malformations (e.g., double outlet right ventricle, transposition of the great arteries, and common truncus arteriosus) were induced in progeny of pregnant mice by retinoic acid administration at day 8.5 of pregnancy. RESULTS: Although control hearts exhibited areas in which capillaries tended to be oriented in parallel arrays, the orientation of capillaries in the respective areas of malformed hearts was chaotic and disorganized. The major branch of a conal vein in control hearts runs usually from the left side of the conus to its right side at the root of the pulmonary trunk and opens to the right atrium below the right auricle; thus, it has a curved course. On the other hand, a conal vein in malformed hearts courses from the left side or from the anterior side of the conus and tends to traverse straight upwards along the dextroposed aorta or along the aortopulmonary groove with its proximal part located outside of the heart. Other cardiac veins in outflow tract malformations are positioned in the same locations as in control hearts. CONCLUSIONS: We postulate that the changed location of the conal vein and disorganized capillary plexus result from malformed morphogenesis of the outflow tract and/or a disturbed regulation of angiogenic growth factor release from the adjacent environment. Birth Defects Research (Part A), 2009.
- Open Access
- 24 September 2008
- Published by Wiley in Developmental Dynamics
- Vol. 237 (10) , 2973-2986
Development of lymphatic vessels in mouse embryonic and early postnatal hearts
We aimed to study the spatiotemporal pattern of lymphatic system formation in the embryonic and early postnatal mouse hearts. The first sign of the development of lymphatics are Lyve‐1–positive cells located on the subepicardial area. Strands of Lyve‐1–positive cells occur first along the atrioventricular sulcus of the diaphragmatic surface and then along the great arteries. Lumenized tubules appear, arranged in rows or in a lattice. They are more conspicuous in dorsal atrioventricular junction, along the major venous and coronary artery branches and at the base of the aorta and the pulmonary trunk extending toward the heart apex. At later stages, some segments of the lymphatic vessels are partially surrounded by smooth muscle cells. Possible mechanisms of lymphangiogenesis are: addition of Lyve‐1–positive cells to the existing tubules, elongation of the lymphatic lattice, sprouting and coalescence of tubules. We discuss the existence of various subpopulations of endothelial cells among the Lyve‐1–positive cells. Developmental Dynamics 237:2973–2986, 2008.
- 24 September 2008
- Published by Wiley in Developmental Dynamics
- Vol. 237 (10) , 2973-2986
Open AccessDevelopment of lymphatic vessels in mouse embryonic and early postnatal hearts
We aimed to study the spatiotemporal pattern of lymphatic system formation in the embryonic and early postnatal mouse hearts. The first sign of the development of lymphatics are Lyve‐1–positive cells located on the subepicardial area. Strands of Lyve‐1–positive cells occur first along the atrioventricular sulcus of the diaphragmatic surface and then along the great arteries. Lumenized tubules appear, arranged in rows or in a lattice. They are more conspicuous in dorsal atrioventricular junction, along the major venous and coronary artery branches and at the base of the aorta and the pulmonary trunk extending toward the heart apex. At later stages, some segments of the lymphatic vessels are partially surrounded by smooth muscle cells. Possible mechanisms of lymphangiogenesis are: addition of Lyve‐1–positive cells to the existing tubules, elongation of the lymphatic lattice, sprouting and coalescence of tubules. We discuss the existence of various subpopulations of endothelial cells among the Lyve‐1–positive cells. Developmental Dynamics 237:2973–2986, 2008.